SALT LAKE CITY, UT, Apr 23, 2008 (MARKET WIRE via COMTEX News Network) -- Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
DATE: May 6, 2008 TIME: 10:00 am ET DOMESTIC DIAL-IN: (800) 926-4420 INTERNATIONAL DIAL-IN: (212) 231-2905 RESERVATION NO.: 21381718 (Please dial in approximately 10 minutes before the call is scheduled to begin)
A press release will be issued at 6:30 am ET.
Replay of the call will be available from two hours after the call for seven days. It can be accessed by dialing (800) 633-8284 from the United States, or +1 402 977 9140 internationally, and entering the reservation number.
Live audio webcast of the call will be available at: www.myriad.com
Contact: Suzanne Barton Myriad Genetics (801) 584-1138
SOURCE: Myriad Genetics, Inc.